Meeting ReportOncology: Basic, Translational & Therapy: Basic Science
Pretargeting of prostate cancer with an internalizing anti-EGP-1 x anti-HSG bispecific antibody
Catharina van Rij, Cathelijne Frielink, Robert Sharkey, David Goldenberg, W. McBride, Edmund Rossi, Chien-Hsing Chang, Wim Oyen and Otto Boerman
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1680;
Catharina van Rij
1Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
Cathelijne Frielink
1Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
Robert Sharkey
2Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, NJ
David Goldenberg
2Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, NJ
W. McBride
3Immunomedics, Inc., Morris Plains, NJ
Edmund Rossi
4IBC Pharmaceuticals, Inc., Morris Plains, NJ
Chien-Hsing Chang
3Immunomedics, Inc., Morris Plains, NJ
Wim Oyen
1Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
Otto Boerman
1Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
In this issue
Pretargeting of prostate cancer with an internalizing anti-EGP-1 x anti-HSG bispecific antibody
Catharina van Rij, Cathelijne Frielink, Robert Sharkey, David Goldenberg, W. McBride, Edmund Rossi, Chien-Hsing Chang, Wim Oyen, Otto Boerman
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1680;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.